Block Drug

Block Drug Company
Nasdaq: BLOC
IndustryPharmaceutical
Founded1907; 119 years ago (1907)
Defunct2001; 25 years ago (2001)
FateAcquired by GSK
SuccessorGlaxoSmithKline (now GSK plc)
(2001-2022)
Haleon(Consumer Products)
(2022-present)
HeadquartersJersey City, New Jersey, United States
Key peopleAlexander Block, Leonard Block, Thomas Block, Michael P. Danziger
ProductsPolident, Poli-Grip, Dentu-Creme, Nytol, Tegrin, Lava Soap, Beano, Phazyme, Balmex, Sensodyne
Number of employees
3,000

Block Drug Company was a pharmaceutical company based in Jersey City, New Jersey, United States, that specialized in dental care products. Its most popular products included Polident denture cleanser, Poli-Grip denture adhesive, Dentu-Creme denture toothpaste, Nytol sleeping pill, Tegrin medicated shampoo for psoriasis, Lava hand soaps (acquired from Procter & Gamble), Beano and Phazyme anti-gas products, Balmex diaper rash ointments, and Sensodyne desensitizing toothpaste.

GlaxoSmithKline (now GSK plc) purchased the company for $1.24 billion in 2001.

History

The company was founded in 1907 by Alexander Block, a Russian immigrant who had a small drugstore on Fulton Street in Brooklyn, New York. He turned the company into a wholesaler in 1915, then became a drug manufacturer in 1925, acquiring a 50 percent interest in Wernet's Dental Manufacturing Company.

Block Drug moved its headquarters to Jersey City, New Jersey in 1938.

Although Alexander Block built the company largely through acquisitions, he developed the Polident brand internally during the 1930s. After Alexander Block's death in 1953, his son Leonard N. Block (1911–2005) took over, eventually becoming the company's chairman.

Timeline

Secrecy

Although Block Drug was a public company from 1971 until 2001, it operated much like a private, family-run firm, with the Block family holding all voting shares plus 54 percent of the non-voting stock. In addition, the company never held annual meetings or issued proxy statements.

Aftermath

at Some point in 2003, GlaxoSmithKline sold Balmex to Johnson & Johnson(Which would later spin-off its consumer healthcare as Kenvue, a Major Rival to Haleon), However there was no record of it happening in the news, the only proof that it did happen was in Balmex's website where it did move from GSK to JNJ. In 2006, as a result of JNJ acquiring Pfizer Consumer Healthcare, Balmex along with 4 other brands got sold to Chattem

Leonard N. Block died in 2005 at age 93 after suffering for years from Alzheimer's disease. Block's nephew John P. Roberts was the producer of the Woodstock using money from his Block inheritance.

In 2011, GSK sold a majority of former Block Drug Brands to Prestige Consumer Healthcare but excludes its oral healthcare brands.

In 2022, GSK spun off its consumer healthcare company as Haleon, which includes their Oral Healthcare Brands

References

  1. 1 2 The Gale Group. International Directory of Company Histories, republished at "Block Drug Company, Inc.: Information from Answers.com". Answers Corporation.
  2. 1 2 GlaxoSmithKline Completes the Purchase of Block Drug for $1.24 Billion Prnewswire (January 16, 2001)
  3. ↑ Hall, John. "Briefing: Pharmaceuticals; Drug Company" The New York Times (October 15, 2000)
  4. 1 2 3 Saxon, Wolfgang (2005-11-12). "Leonard Block, 93, Chief of Drug Company, Is Dead". The New York Times. Retrieved 2010-04-26.
  5. 1 2 3 4 5 6 "New Chip at the Old Block?". Forbes. May 29, 1978. p. 48.
  6. ↑ "NEW PRODUCTS: The Teeth of Battle". time.com. May 23, 1949. Retrieved 25 August 2025.
  7. ↑ "8-top-toothpastes-criticized-by-fda". nytimes.com. 1970-07-21. Retrieved 25 August 2025.
  8. 1 2 3 4 5 6 7 8 9 10 Goldblatt, Dan (September 7, 1994). "New Jersey's most private public company". Northern Business. p. 48.
  9. 1 2 3 4 5 "History of Block Drug Company, Inc. – FundingUniverse". www.fundinguniverse.com.
  10. ↑ "New Chip at the Old Block?". Chicago Sun-Times. May 29, 1978. p. 48.
  11. ↑ "Stanback to leave Rowan". www.bizjournals.com. Retrieved 2019-05-28.
  12. ↑ Clark, Andrew (October 7, 2000). "SmithKline to swallow Sensodyne: Aquafresh maker lines up Dollars 1.2bn bid for privately owned toothpaste company Block Drug". The Guardian (London). p. 29.